Skip to main content
. 2017 Feb 22;73(Pt 3):240–245. doi: 10.1107/S2059798317000675

Figure 7.

Figure 7

Systematic changes of a GPR119 agonist leading to increased solubility owing to crystal engineering. (a) Solubility 0.03 µM. (b) Self–self association of terminal groups of molecule A in the structural lattice of CSD Refcode SEMPAD. (c) Solubility 6 µM.